Literature DB >> 7652929

Therapeutic uses of heparin beyond its traditional role as an anticoagulant.

D J Tyrell1, S Kilfeather, C P Page.   

Abstract

A number of physiological effects have been ascribed to heparin since its discovery almost 80 years ago, many of which are independent from its first-described and best- characterized activity as an anticoagulant. Heparin and heparan sulphate are believed to possess many biological activities that include the ability to modulate embryonic development, neurite outgrowth, tissue homeostasis, wound healing, metastasis, cell differentation, cell proliferation and inflammation. In this review, David Tyrell, Stephen Kilfeather and Clive Page examine some of the activities of heparin (and heparin derivatives) beyond its effects as an anticoagulant, and discuss the therapeutic potential of this old, but certainly not antiquated, drug.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7652929     DOI: 10.1016/s0165-6147(00)89022-7

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  37 in total

1.  Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin.

Authors:  Hui-Fei Cui; Xue-Liang Jiang
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis.

Authors:  S M Smorenburg; R Vink; M te Lintelo; W Tigchelaar; A Maas; H R Büller; C J van Noorden
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

3.  Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin.

Authors:  James W Murphy; Yoonsang Cho; Aristidis Sachpatzidis; Chengpeng Fan; Michael E Hodsdon; Elias Lolis
Journal:  J Biol Chem       Date:  2007-01-29       Impact factor: 5.157

4.  The effects of heparin and related molecules on vascular permeability and neutrophil accumulation in rabbit skin.

Authors:  Helen Jones; William Paul; Clive P Page
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation.

Authors:  Jens Dernedde; Alexandra Rausch; Marie Weinhart; Sven Enders; Rudolf Tauber; Kai Licha; Michael Schirner; Ulrich Zügel; Arne von Bonin; Rainer Haag
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

6.  Structure Activity Relationship of Heparin Mimicking Polymer p(SS-co-PEGMA): Effect of Sulfonation and Polymer Size on FGF2-Receptor Binding.

Authors:  Samantha J Paluck; Heather D Maynard
Journal:  Polym Chem       Date:  2017-07-05       Impact factor: 5.582

7.  Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial.

Authors:  Elisabeth Pasquier; Luc de Saint Martin; Caroline Bohec; Céline Chauleur; Florence Bretelle; Gisèle Marhic; Grégoire Le Gal; Véronique Debarge; Frédéric Lecomte; Christine Denoual-Ziad; Véronique Lejeune-Saada; Serge Douvier; Michel Heisert; Dominique Mottier
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

8.  Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial.

Authors:  I Dotan; A Hallak; N Arber; M Santo; A Alexandrowitz; Y Knaani; R Hershkoviz; E Brazowski; Z Halpern
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

9.  Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.

Authors:  Brijeshkumar Patel; Nilesh Gupta; Fakhrul Ahsan
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-11-28       Impact factor: 2.849

10.  Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysis.

Authors:  Derek J Langeslay; Consuelo N Beecher; Annamaria Naggi; Marco Guerrini; Giangiacomo Torri; Cynthia K Larive
Journal:  Anal Chem       Date:  2012-12-31       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.